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A glycosylated form of recombinant human insulin-like growth factor I (IGF-I) expressed in Succharomyces cerevisiae 
was shown to contain mannose as the only carbohydrate constituent. All oligosaccharide chains of the glycoprotein could 
be released by mild alkaline treatment, and separated from the protein by gel-permeation chromatography on Bio-Gel 
P-2. The structures of these O-linked carbohydrate chains were determined by W-MHz ‘H-NMR spectroscopy, afford- 
ing the disaccharide Manal-2Man as the major component and the tetrasaccharide Manul-3Manal-ZManal-2Man as 
a minor component. Reference oligosaccharides were prepared from mannoproteins released from the cell wall of S. 
cerevisiae X2180 (a-wild type). In addition to previously reported structures, ranging from mannose to mannotetraose, 
the pentasaccharide Manccl-3Mana1-3ManaI-2Manal-2Man was identified in the cell wall mannoprotein. 
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1. INTRODUCTION 
There is great interest in the yeast Saccharo- 
myces cerevisiae as a host for the biotechnological 
production of recombinant human (glyco)pro- 
teins, since it is relatively easy for one to 
manipulate this eukaryotic organism which can be 
cultured in large amounts [l-3]. Especially for 
recombinant glycoproteins with a pharmacological 
application, knowledge of the exact structure of 
the carbohydrate chains is required. Glycosylation 
may influence the secretion efficiency [4], 
biological activity [4,5] and stability of the protein 
[6]. Furthermore, yeast-specific glycans on a 
human protein may introduce new immunological 
determinants. The glycosylation machinery in 
yeast can produce both N- and O-linked glycans 
[2]. N-linked glycans from yeast possess the same 
core structure as is found in human glycoproteins, 
but yeast N-glycans often contain highly branched 
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mannans. In contrast to most other eukaryotic 
organisms the 0-glycosidic carbohydrate chains in 
yeast are linked via mannose to serine or threonine 
[7]. However, despite the rapid development in 
yeast gene-cloning research, there are no reports 
about the detailed structure of the glycans present 
on human proteins expressed in yeast [l]. 
Here, we report on the carbohydrate structures 
present in a glycosylated form of recombinant 
human insulin-like growth factor I (IGF-I or 
somatomedin C) expressed in S. cerevisiae. Human 
serum IGF-I is not glycosylated, but the recombi- 
nant human IGF-I from yeast can be separated in- 
to both an unglycosylated and a glycosylated form 
(Gellerfors, P., personal communication). 
2. MATERIALS AND METHODS 
2.1. Insulin-like growth factor I 
The recombinant glycosylated human IGF-I preparation used 
here was provided by Dr P. Gellerfors (Kabi, Stockholm, 
Sweden). The concentration of IGF-I was determined by 
radioreceptor assay using placental membrane, the specific ac- 
tivity being 15000 U/mg protein. 
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2.2. Isolation of yeast cell wall mannoprotein 
Reference oligosaccharides were prepared from yeast cell wall 
mannoprotein, solubilized from the cell wall of S. cerevisiae 
X2180 @-wild type) by boiling in the presence of 2% (w/w) 
SDS, according to [8]. 
2.3. Liberation and isolation of O-linked carbohydrate chains 
The O-linked carbohydrate chains were released by alkaline 
treatment as described 171. Recombinant IGF-I (16 mg) was 
dissolved in 16 ml of 0.1 M NaOH and incubated for 18 h at 
21 “C. After neutralization with 2 M acetic acid and lyophiliza- 
tion, the released oligosaccharides were separated from the pro- 
tein by gel filtration on a column (1.2 x 50 cm) of Bio-Gel P-2 
(200-400 mesh, Bio-Rad) using water as eluent at a flow rate 
of 6 ml/h. The carbohydrate-positive fractions (or- 
cinol/sulfuric acid spot test) were pooled and desalted on a col- 
umn (1.2 x 8 cm) containing equal layers of AGl X-2 
(acetate-form, 200-400 mesh, Bio-Rad) and AG 5OW 
(H+-form) with water as eluent. 
The reference saccharides were released from 405 mg yeast 
cell wall mannoprotein in 80 ml of 0.1 M NaOH. In addition to 
the previously reported structures Man (Ml), Mancul-2Man 
(MZ), MancYl-2Mancul-2Man (M3) and Mancul-3Mancul-2Man 
ol-2Man (M4) [7], a carbohydrate-positive fraction was ob- 
tained with a larger retention volume on HPLC (Lichrosorb- 
NHz) than M4. The anomeric region of the 500-MHz ‘H-NMR 
spectrum of MS showed five signals of similar intensity. By 
comparing the chemical shift values of the anomeric protons 
with those from reference compounds [9], the oligosaccharide 
was identified as the pentasaccharide Mancul-3Mancul- 
3Mancul-2Mancul-2Man (M5). 
2.4. HPLC 
The oligosaccharide mixture obtained from S. cerevisiae cell 
wall mannoprotein was fractionated on a Kratos Spectroflow 
400 HPLC system (Kratos Analytical) using a Lichrosorb-NH2 
1Orm column (0.46 x 25 cm, Chrompack). Prior to injection, 
samples were dissolved in water (Milli-Q quality). Car- 
bohydrates were eluted isocratically with acetonitrile/water 
(80:20, v/v) at a flow rate of 2 ml/min and monitored at 
195 nm with a Spectroflow 783 absorbance detector (Kratos 
Analytical). 
MFa1-2Man A 1 
Manal-3Manal-2Manal-2Man B 
4 3 2 1 
Fig.1. Anomeric region of the resolution-enhanced 500-MHz ‘H-NMR spectrum of the pool of oligosaccharides obtained from 
recombinant human IGF-I. The low-intensity signals designated by the asterisks at 6 5.462 ppm (Jr,2 = 3.7 Hz) and 6 5.269 ppm (Jt.2 = 
1.5 Hz) probably belong to an as yet unidentified carbohydrate. However, the available amount of IGF-I was too low to permit further 
analysis of the minor compounds. 
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2.5. Monosaccharide analysis 
Samples were subjected to the methanolysis procedure and 
analyzed by GLC on CP-Sil 5, as described [lo]. 
2.6. Reduction of oligosaccharides 
Part of the oligosaccharide mixture obtained from IGF-I was 
reduced with NaBH4 in water (1 ml) for 14 h at room 
temperature. The reaction was terminated by the addition of 
AG 5OW (Hf-form) and the cation-exchange r sin was removed 
by filtration. Boric acid was removed by co-evaporation with 
1% (v/v) acetic acid in methanol. 
2.1. 500-MHz ‘H-NMR spectroscopy 
Carbohydrate samples were repeatedly exchanged in *Hz0 
(finally using 99.96 atom% *H, Aldrich) with intermediate 
lyophilization. Resolution-enhanced 500-MHz ‘H-NMR spec- 
tra were recorded in *Hz0 at 27°C on a Bruker AM-500 spec- 
trometer (Department of Chemistry, Utrecht University). 
Chemical shifts (6) are given relative to internal acetone (S = 
2.225 ppm) [ll]. The two-dimensional homonuclear 
Hartmann-Hahn (HOHAHA) spectrum was obtained using a 
100 ms MLEV-17 mixing sequence [12], recording 512 
measurements of 2K data points with 16 scans per tl value. For 
the two-dimensional double-quantum filtered ‘H-‘H correla- 
tion spectrum (DQF-COSY) [13] 350 measurements of 2K data 
points were performed. The 90” ‘H pulse width was 32.6 PCS and 
the residual HO*H signal was suppressed by presaturation for 
1.0 s. 
3. RESULTS 
Sugar analysis of glycosylated recombinant 
human IGF-I revealed only mannose, and the total 
carbohydrate content was about 8% (w/w). After 
alkaline treatment of IGF-I, the pool of released 
oligosaccharides was isolated by gel-permeation 
chromatography on Bio-Gel P-2 (not shown), 
desalted, and analyzed by 500-MHz ‘H-NMR spec- 
troscopy. As has been shown before, the chemical 
shifts of the H-l and H-2 atoms of manno- 
oligosaccharides are characteristic of both the type 
of linkage and the sequence of the constituent 
monosaccharides [9,14]. The anomeric region of 
the ‘H-NMR spectrum of the mixture of IGF-I 
oligosaccharides is depicted in fig.1. The major 
component turned out to be Mancul-2Man (com- 
pound A), reflected by two about equally intense 
H-l signals at 6 5.380 ppm (Jr.2 = 1.5 Hz) and S 
5.042 ppm (Jr.2 = 1.5 Hz), and having correspond- 
ing H-2 signals at 6 3.96 and 4.073 ppm, stemming 
from the reducing and nonreducing Man residues, 
respectively. The structural reporter groups match 
completely those obtained for the reference M2, 
isolated from the cell wall mannoprotein of S. 
cerevisiae (see table l), but are different from those 
Table 1 
‘H chemical shifts of structural reporter group protons of the 
constituent monosaccharides for the oligosaccharides A and B 
derived from recombinant human IGF-I together with those for 
reference compounds MZ-MS, prepared from yeast cell wall 
mannoprotein 
Reporter Residue” A B M2 M3 M4 MS 
group 
H-l lff 5.381 5.371 5.380 5.370 5.371 5.371 
Ip 4.918 n.d. 4.918 n.d. n.d. n.d. 
2 5.042 5.297 5.042 5.299 5.297 5.296 
3 - 5.032 - 5.044 5.033 5.036 
4 - 5.147 - - 5.142 5.121 
5 - - _ _ _ 5.137 
H-2 1CY 3.96 3.96 n.d. 3.960 n.d. n.d. 
la 4.073 n.d. n.d. n.d. n.d. n.d. 
2 4.073 4.11 4.073 4.109 4.11 n.d. 
3 _ 4.23 - 4.065 4.221 n.d. 
4 - 4.07 - - 4.068 n.d. 
H-3 1 3.69 n.d. n.d. n.d. n.d. n.d. 
2 3.86 n.d. n.d. n.d. n.d. n.d. 
a For numbering of monosaccharide residues, see fig.1 
n.d., not determined. Chemical shifts are given in *Hz0 at 
300 K relative to internal acetone (S 2.225 ppm) 
reported for the ~~1-3, al-4, and cul-6-linked 
mannosyl-mannoses [9]. The assignments of addi- 
tional protons for the IGF-I disaccharide, as given 
in table 1, were made using COSY and HOHAHA 
experiments. The disaccharide accounts for about 
80 mol% of the oligosaccharides present in IGF-I, 
estimated by integrating the anomeric region of the 
‘H-NMR spectrum of the mixture of oligosac- 
char-ides. 
In addition to the disaccharide, small amounts 
of Manal -3Mancu l -2Mancu l -2Man (compound B) 
could be identified. The most indicative structural 
reporter group signals for this tetrasaccharide are 
the H-l signals at S 5.147 and 5.032 ppm, being 
characteristic for the terminal Cal-3-linked Man-4 
and the subterminal 3-substituted al-2-linked 
Man-3, respectively. From the HOHAHA experi- 
ment the corresponding H-2 signals were assigned 
to 6 4.07 ppm (Man-4) and 6 4.23 ppm (Man-3). 
The signal at 6 5.371 ppm is assigned to H-l of the 
cY-anomer of Man-l, with the H-2 signal at 6 
3.79 ppm, whereas the H-l of Man-2 resonates at 
6 5.297 ppm, with the H-2 signal at 6 4.11 ppm (cf. 
M4, table 1). The relatively high intensity of the 
signal at 6 5.147 ppm, as compared to the signal at 
113 
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S 5.297 ppm, is due to overlap with another, as yet 
unassigned signal, which was detected by a second 
cross-peak in the HOHAHA experiment. In the 
trisaccharide M3 and the tetrasaccharide M4 the 
chemical shift values of the H-l atoms of Man-l 
and Man-2 are the same. However, based on the 
intensities of the signals it can be concluded that 
only trace amounts, if any, of the trisaccharide 
Mancvl-2Manal-2Man can occur in IGF-I. 
4. DISCUSSION 
Here it is shown that Mancvl-2Man is the pre- 
dominant oligosaccharide in a glycosylated form 
of human recombinant IGF-I produced in S. 
cerevisiae. As a minor constituent Manal-3Man 
al -2Mancwl-2Man could be identified. Both 
oligosaccharides are typical yeast 0-glycans, but it 
should be noted that the same carbohydrate 
epitope as in the disaccharide occurs as a terminal 
sequence in several human N-glycoproteins con- 
taining oligomannose-type carbohydrate chains 
[ 151. On the other hand, the tetrasaccharide does 
not normally occur in human glycoproteins and 
strongly reacting antibodies against this yeast 
oligosaccharide have been raised in rabbit [la]. 
The O-linked pentasaccharide Man&l-3Man 
al-3Manal-2Mancul-2Man, which was found in 
yeast cell wall mannoprotein, was not found in the 
recombinant protein, but has previously been 
isolated from S. italicus [ 171. 
In IGF-I there are eight serine or threonine 
residues [181, being potential 0-glycosylation sites. 
It has been shown that a proline residue in the 
vicinity of a serine or threonine residue markedly 
enhances the 0-glycosylation efficiency [ 19,201, 
therefore the most likely glycosylation sites in IGF- 
I are the threonines at positions 4, 29 and 41. The 
lack of N-linked saccharides in IGF-I is explained 
by the absence of an Asn-X-Ser/Thr sequence, re- 
quired for N-glycosylation [21]. 
Acknowledgements: The authors thank Dr Par Gellerfors 
(Kabi, Stockholm, Sweden) for providing glycosylated IGF-I, 
and Dr Frans Klis (Department of Plant Physiology, University 
of Amsterdam, The Netherlands) for help with the isolation of 
yeast cell wall mannoprotein. This investigation was supported 
by the Netherlands Foundation for Chemical Research (SON) 
with financial aid from the Netherlands Organization for Scien- 
tific Research (NWO), and by the Netherlands Innovation 
Directed Research Program for Carbohydrates (IOP-K). K.H. 
was partially supported by a grant from Suomen Kult- 
tuurirahasto (Finland). 
REFERENCES 
[II 
PI 
131 
[41 
PI 
Kukuruzinska, M.A., Bergh, M.L.E. and Jackson, B.J. 
(1987) Annu. Rev. Biochem. 56, 915-944. 
Tanner, W. and Lehle, L. (1987) Biochim. Biophys. Acta 
906, 81-99. 
Hinnen, A., Heim, J. and Meyhack, B. (1988) Yeast 4, 
S26. 
Gill, G.S., Zaworski, P.G., Marotti, K.R. and Rehberg, 
E.F. (1988) Yeast 4, S148. 
Moonen, P., Mermod, J.-J., Ernst, J.F., Hirschi, M. and 
DeLamarter, J.F. (1987) Proc. Natl. Acad. Sci. USA 84, 
4428-443 1. 
El 
171 
PI 
191 
1101 
illI 
1121 
P31 
1141 
Van Arsdell, J.N., Kwok, S., Schweikart, V.L., Ladner, 
M.B., Gelfand, D.H. and Innis, M.A. (1987) 
Bio/Technology 5, 60-64. 
Nakajima, T. and Ballou, C.E. (1974) J. Biol. Chem. 249, 
7679-7684. 
Valentin, E., Herrero, E., Pastor, F.I.J. and Sentandreu, 
R. (1984) J. Gen. Microbial. 130, 1419-1428. 
Cohen, R.E. and Ballou, C.E. (1980) Biochemistry 19, 
4345-4358. 
Kamerling, J.P. and Vliegenthart, J.F.G. (1982) Cell 
Biol. Monogr. 10, 92-125. 
Vliegenthart, J.F.G., Dorland, L. and Van Halbeek, H. 
(1983) Adv. Carbohydr. Chem. Biochem. 41, 209-374. 
Bax, A. and Davis, D.G. (1985) J. Magn. Res. 65, 
355-360. 
Marion, D. and W&rich, K. (1985) Biochem. Biophys. 
Res. Commun. 117, 967-974. 
Van Halbeek, H., Dorland, L., Veldink, G.A., 
Vliegenthart, J.F.G., Michalski, J.-C., Montreuil, J., 
Strecker, G. and Hull, W.E. (1980) FEBS Lett. 121, 
65-70. 
PSI Kobata, A. (1984) in: Biology of Carbohydrates, vol.2 
(Ginsburg, V. and Robbins, P.W. eds) pp.87-161, Wiley, 
New York. 
1161 
iI71 
[I81 
1191 
WI 
Zopf, D.A., Tsai, C.-M. and Ginsburg, V. (1978) Arch. 
Biochem. Biophys. 185, 61-71. 
Ballou, C.E., Lipke, P.N. and Raschke, W.C. (1974) J. 
Bacterial. 117, 461-467. 
Rinderknecht, E. and Humbel, R.E. (1978) J. Biol. 
Chem. 253, 2769-2776. 
Lehle, L. and Bause, E. (1984) Biochim. Biophys. Acta 
799, 246-25 1. 
Fiat, A.M., Jolles, J., Aubert, J.P., Loucheux-Lefebvre, 
M.H. and Jolles, P. (1980) Eur. J. Biochem. 111, 
333-339. 
Pll Marshall, R.D. (1972) Annu. Rev. Biochem. 41,673-702. 
114 
